Correlation of s-CD44 With 8 Clinicopathologic Factors in NHL
| Variable . | s-CD44* . | P Value . | |
|---|---|---|---|
| . | ≤440 ng/mL . | >440 ng/mL . | . |
| Stage (N = 192) | |||
| I | 46 (71) | 19 (29) | <.0001 |
| II | 29 (58) | 21 (42) | |
| III | 13 (41) | 19 (59) | |
| IV | 9 (20) | 36 (80) | |
| s-LDH (N = 184) | |||
| ≤450 U/L | 76 (59) | 53 (41) | .0005 |
| >450 U/L | 17 (31) | 38 (69) | |
| B symptoms (N = 193) | |||
| No | 86 (56) | 69 (45) | .003 |
| Yes | 11 (29) | 27 (71) | |
| Age (N = 198) | |||
| ≤59 yr (median) | 57 (58) | 41 (42) | .02 |
| > 59 yr | 40 (42) | 56 (58) | |
| WHO performance status (N = 194) | |||
| 0 | 61 (59) | 42 (41) | .02 |
| 1 | 22 (37) | 37 (63) | |
| 2-4 | 14 (44) | 18 (56) | |
| No. of extranodal sites (N = 192) | |||
| 0-1 | 91 (53) | 81 (47) | .05 |
| >1 | 6 (30) | 14 (70) | |
| Gender (N = 194) | |||
| Male | 50 (57) | 38 (43) | .08 |
| Female | 47 (44) | 59 (56) | |
| Grade WF (N = 186) | |||
| Low | 25 (52) | 23 (48) | .31 |
| Intermediate | 39 (43) | 51 (57) | |
| High | 27 (56) | 21 (44) | |
| Variable . | s-CD44* . | P Value . | |
|---|---|---|---|
| . | ≤440 ng/mL . | >440 ng/mL . | . |
| Stage (N = 192) | |||
| I | 46 (71) | 19 (29) | <.0001 |
| II | 29 (58) | 21 (42) | |
| III | 13 (41) | 19 (59) | |
| IV | 9 (20) | 36 (80) | |
| s-LDH (N = 184) | |||
| ≤450 U/L | 76 (59) | 53 (41) | .0005 |
| >450 U/L | 17 (31) | 38 (69) | |
| B symptoms (N = 193) | |||
| No | 86 (56) | 69 (45) | .003 |
| Yes | 11 (29) | 27 (71) | |
| Age (N = 198) | |||
| ≤59 yr (median) | 57 (58) | 41 (42) | .02 |
| > 59 yr | 40 (42) | 56 (58) | |
| WHO performance status (N = 194) | |||
| 0 | 61 (59) | 42 (41) | .02 |
| 1 | 22 (37) | 37 (63) | |
| 2-4 | 14 (44) | 18 (56) | |
| No. of extranodal sites (N = 192) | |||
| 0-1 | 91 (53) | 81 (47) | .05 |
| >1 | 6 (30) | 14 (70) | |
| Gender (N = 194) | |||
| Male | 50 (57) | 38 (43) | .08 |
| Female | 47 (44) | 59 (56) | |
| Grade WF (N = 186) | |||
| Low | 25 (52) | 23 (48) | .31 |
| Intermediate | 39 (43) | 51 (57) | |
| High | 27 (56) | 21 (44) | |
The median (440 ng/mL) was used as the cut-off value.
Values are the number of patients with the percentage in parentheses.